$8.91
1.02%
Nasdaq, Sep 25, 04:00 pm EDT. Closed.
ISIN
CA92663R1055
Symbol
VMD

Viemed Healthcare Inc Target price 2026 - Analyst rating & recommendation

Viemed Healthcare Inc Classifications & Recommendation

Buy
71%
Hold
29%

Viemed Healthcare Inc Price Target

Target Price $12.75
Price $8.91
Potential
Number of Estimates 3
3 Analysts have issued a price target Viemed Healthcare Inc 2027 . The average Viemed Healthcare Inc target price is $12.75. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 7 analysts: 5 Analysts recommend Viemed Healthcare Inc to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Viemed Healthcare Inc stock has an average upside potential 2027 of . Most analysts recommend the Viemed Healthcare Inc stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million $ 270.28 321.12
20.52% 18.81%
EBITDA Margin 8.21% 20.45%
5.38% 148.97%
Net Margin 5.52% 4.95%
9.92% 10.39%

4 Analysts have issued a sales forecast Viemed Healthcare Inc 2026 . The average Viemed Healthcare Inc sales estimate is

$321m
unlock
. This is
6.47% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$335m 11.05%
unlock
, the lowest is
$311m 3.07%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $270m 20.52%
2026
$321m 18.81%
unlock
2027
$357m 11.23%
unlock
2028
$404m 13.09%
unlock
2029
$466m 15.47%
unlock
2030
$518m 11.11%
unlock
2031
$570m 10.00%
unlock
2032
$614m 7.80%
unlock
2033
$654m 6.51%
unlock

4 Analysts have issued an Viemed Healthcare Inc EBITDA forecast 2026. The average Viemed Healthcare Inc EBITDA estimate is

$65.7m
unlock
. This is
152.09% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$69.3m 166.03%
unlock
, the lowest is
$63.0m 141.74%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $22.2m 27.00%
2026
$65.7m 195.81%
unlock
2027
$75.1m 14.39%
unlock
2028
$86.2m 14.73%
unlock

EBITDA Margin

2025 8.21% 5.38%
2026
20.45% 148.97%
unlock
2027
21.03% 2.84%
unlock
2028
21.34% 1.47%
unlock

4 Viemed Healthcare Inc Analysts have issued a net profit forecast 2026. The average Viemed Healthcare Inc net profit estimate is

$15.9m
unlock
. This is
9.66% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$17.2m 18.62%
unlock
, the lowest is
$14.6m 0.41%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $14.9m 32.48%
2026
$15.9m 6.50%
unlock
2027
$20.9m 31.45%
unlock
2028
$26.5m 26.99%
unlock

Net Margin

2025 5.52% 9.92%
2026
4.95% 10.39%
unlock
2027
5.85% 18.18%
unlock
2028
6.57% 12.31%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ 0.37 0.42
32.14% 13.51%
P/E 21.34
EV/Sales 1.03

4 Analysts have issued a Viemed Healthcare Inc forecast for earnings per share. The average Viemed Healthcare Inc EPS is

$0.42
unlock
. This is
16.67% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$0.45 25.00%
unlock
, the lowest is
$0.38 5.56%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $0.37 32.14%
2026
$0.42 13.51%
unlock
2027
$0.55 30.95%
unlock
2028
$0.70 27.27%
unlock

P/E ratio

Current 24.75 25.04%
2026
21.34 13.78%
unlock
2027
16.24 23.90%
unlock
2028
12.79 21.24%
unlock

Based on analysts' sales estimates for 2026, the Viemed Healthcare Inc stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.09 6.86%
2026
1.03 5.81%
unlock
2027
0.92 10.10%
unlock
2028
0.82 11.57%
unlock
2029
0.71 13.40%
unlock
2030
0.64 9.99%
unlock
2031
0.58 9.10%
unlock
2032
0.54 7.23%
unlock
2033
0.50 6.11%
unlock

P/S ratio

Current 1.11 1.97%
2026
1.04 6.08%
unlock
2027
0.93 10.09%
unlock
2028
0.83 11.57%
unlock
2029
0.71 13.40%
unlock
2030
0.64 9.99%
unlock
2031
0.58 9.10%
unlock
2032
0.54 7.22%
unlock
2033
0.51 6.12%
unlock

Current Viemed Healthcare Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Barrington Research
Locked
➜
Locked
Locked Aug 24 2026
Freedom Broker
Locked
➜
Locked
Locked Aug 06 2026
Analyst Rating Date
Locked
Barrington Research:
Locked
➜
Locked
Aug 24 2026
Locked
Freedom Broker:
Locked
➜
Locked
Aug 06 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today